Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

bloomberg.com - Goldman's Haider: Pivotal Year for Obesity Market in Pharma
Goldman's Haider: Pivotal Year for Obesity Market in Pharma
Bloomberg

Asad Haider, head of the U.S. Healthcare Business Unit at Goldman Sachs Research, says 2026 is a pivotal year for the obesity market due to upcoming oral drug launches. He tells Romaine Bostick and Katie Greifeld on “The Close” that…

indianexpress.com - MoUs worth Rs 10,000 crore inked at UP Pharma Conclave
MoUs worth Rs 10,000 crore inked at UP Pharma Conclave
The Indian Express

5 min read Lucknow Make us preferred source on Google The Uttar Pradesh government on Tuesday signed memorandums of understanding (MoUs) worth Rs 10,000 crore with pharmaceutical companies at the ‘Uttar Pradesh Pharma Conclave 1.0' in…

thehindu.com - The Hindu Bureau - Natco Pharma gets U.S. FDA tentative nod for generic of Janssen's cancer drug
Natco Pharma gets U.S. FDA tentative nod for generic of Janssen's cancer drug
The Hindu

Natco Pharma has received U.S. Food and Drug Administration's tentative approval for Erdafitinib Tablets 3 mg, 4mg, and 5 mg, a generic version of Janssen Biotech cancer drug Balversa. Erdafitinib tablets had estimated sales of $60 million in the…

thehindubusinessline.com - Broker's call: Glenmark Pharma (Add)
Broker's call: Glenmark Pharma (Add)
BusinessLine

Glenmark Pharmaceuticals' revenue grew 15.1 per cent year on year and de-grew 35.5 per cent quarter on quarter to ₹3,900.60 crore (vs. our estimate: ₹4,227.20 crore). EBITDA grew 44.9 per cent y-o-y and de-grew 63.1 per cent q-o-q to…

thehindubusinessline.com - Natco Pharma gets USFDA nod for cancer generic drug
Natco Pharma gets USFDA nod for cancer generic drug
BusinessLine

Natco Pharma has received tentative approval from the US Food and Drug Administration (USFDA) for Erdafitinib, a generic version of Balversa by Janssen Biotech Inc. The Hyderabad-based Natco's Erdafitinib is indicated for the treatment of adult…

marketbeat.com - aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Recommendation of 'Hold' by Brokerages
aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Recommendation of 'Hold' by Brokerages
MarketBeat

Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) have been assigned an average recommendation of 'Hold' from the seven ratings firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock…

marketbeat.com - Marshall Urist Sells 20,000 Shares of Royalty Pharma (NASDAQ:RPRX) Stock
Marshall Urist Sells 20,000 Shares of Royalty Pharma (NASDAQ:RPRX) Stock
MarketBeat

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 20,000 shares of the stock in a transaction dated Friday, January 30th. The stock was sold at an average price of $41.09, for a total value of $821,800.00. The sale was…

marketbeat.com - Y Intercept Hong Kong Ltd Has $724,000 Stock Holdings in BridgeBio Pharma, Inc. $BBIO
Y Intercept Hong Kong Ltd Has $724,000 Stock Holdings in BridgeBio Pharma, Inc. $BBIO
MarketBeat

Y Intercept Hong Kong Ltd trimmed its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 93.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,931…

globenewswire.com - Pharma Equity Group A/S - 2026 Financial Calendar
2026 Financial Calendar
GlobeNewswire

​March 4Deadline for shareholder proposals - Annual General meeting​ ​March 18 ​Annual Report 2025​ April 16Annual General Meeting​ August 14Interim Report – for the six-month period ended June 30.

rediff.com - Rediff News - Investors became richer by Rs 12.10 lakh cr today
Investors became richer by Rs 12.10 lakh cr today
Rediff.com

Stock investors' wealth surged by Rs 12.10 lakh crore on Tuesday, tracking a sharp rally in equities buoyed by the India-US trade deal. The 30-share BSE Sensex jumped 4,205.27 points or 5.14 per cent to hit the day's high of 85,871.73. It later…

rediff.com - Nandita Malik - Sensex surged 2,073 points, Nifty closed
Sensex surged 2,073 points, Nifty closed
Rediff.com

Reduction of US tariffs on Indian goods from 50 per cent to 18 per cent enhances India's competitive position among emerging markets. From the 30 Sensex firms, Adani Ports surged 9.12 per cent Prominent winners were Bajaj Finance, InterGlobe…

deccanchronicle.com - Vujjini Vamshidhar - Telangana HC Grants Bail to Sigachi Industries MD in Sangareddy Blast Case
Telangana HC Grants Bail to Sigachi Industries MD in Sangareddy Blast Case
Deccan Chronicle

Hyderabad: The Telangana High Court has granted bail to Amith Raj Sinha, managing director and chief executive officer of Sigachi Industries, who had been in judicial custody for over a month after being arrested in connection with the June 30…

thehindu.com - Pti - Stock markets cheer India-U.S. trade deal: Sensex, Nifty surge 2.5%
Stock markets cheer India-U.S. trade deal: Sensex, Nifty surge 2.5%
The Hindu

Stock market benchmark indices Sensex and Nifty ended 2.5% higher on Tuesday (February 3, 2026) after India and the U.S. agreed to a trade deal under which Washington will bring down the reciprocal tariff on Indian goods to 18%. After starting the…

deccanchronicle.com - PTI - Stock Markets Cheer India-US Trade Deal: Sensex, Nifty Surge 2.5 Pc
Stock Markets Cheer India-US Trade Deal: Sensex, Nifty Surge 2.5 Pc
Deccan Chronicle

Mumbai: Stock market benchmark indices Sensex and Nifty ended 2.5 per cent higher on Tuesday after India and the US agreed to a trade deal under which Washington will bring down the reciprocal tariff on Indian goods to 18 per cent. After starting…

wsj.com - Nicholas G. Miller - Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand
Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand
Wall Street Journal

reported lower fourth-quarter sales as demand for its Covid-19 vaccine and antiviral drug continued to decline. The drugmaker reported a loss of $1.65 billion, or 29 cents a share, compared with a profit of $410 million, or 7 cents a share, the…

Receive a Daily briefing on Pharma Industry News

Get Started